Melatonin exhibits antioxidant properties in a mouse brain slice model of excitotoxicity

References

• Babu GN and Bawari M: Single microinjection of L-glutamate induces oxidative stress in discrete regions of rat brain. Bichem and Mol Bio Int 1997; 42:1207–17.
   Google Scholar
• Braham B, Forman RE, Stewart EE, Nicholson C, Rice ME: Ascorbate inhibits edema in brain slices. J Neurochem. 2000; 74:1263–1270.
   Web of Science ®Google Scholar
• Cabrera J, Reiter RJ, Tan D-X, et al. Melatonin reduces oxidative neurotoxicity due to quinolinic acid: In vitro and in vivo findings, Neuropharm 2000; 39:507–514.
   Google Scholar
• Cazevieille C, Safa R, and Osborne NN. Melatonin protects primary cultures of rat cortical neurons from NMDA excitotixicity and hypoxia/reoxygenation. Brain Research 1997; 768:120–124.
   Google Scholar
• Chan PH. New insights into the role ofoxygen radicals in cerebral ischemia. In: Bazan NG, Braquet 1 Ginsberg M. Advances in Neurochemistry, volume 7, Neurochemi-cal Correlates of Crebral Ischemia. Plenum Press, NewYork. 1992; 277–294.
   Google Scholar
• Choi DW. Excitoxic Cell Death J. Neurobiology 1992; 23:1261–1276.
   Google Scholar
• Clapp, KL. Investigations into model systems of Neurodegeneration: Organotypic Brain Slice Culture and in vivo microdialysis. Ph.D. Thesis, 2000. Univ of Alaska Fairbank s. 104pp.
   Google Scholar
• Didier M, Bursztajn S, Adamee E, et al. DNA strand breaks induced by sustained glutamate excitotoxicity in primary neuronal cultures. J Neuroscience 1996; 16:2238–2250.
   PubMed Web of Science ®Google Scholar
• Dykens JA, Stern A, Trekner E. Mechanismof kainite toxicity to cerbellar neurons in vitor is analogous to reperfusion tissue injury. J. Neurochem 1987; 49:1222–1228.
   Google Scholar
• Feigin V Khasenko V, Tarasov A. Stoke morbidity and mortality in Chukotka. Arctic Med Res 1994: 53: (Suppl. 2)592–593.
   Google Scholar
• Giusti P, Gusella M, Lipartiti M, et al. Melatonin portects primary cultures of cerebellar granule neurons from kanate but not from NMDA excitotoxicity. Exp Neurol. 1995;131:39–46.
   PubMed Web of Science ®Google Scholar
• Giusti P, Lipartiti M, Francheschini D, et al. Neuroprotection by melatonin from kainate-induced excitotoxicity in rats FASEB J 1996; 10:891–6
   Google Scholar
• Joo JY, Uz T, Manev H. Opposite effects of pinealectomy and melatonin administration on brain damage following cerebral focal ischemia in rat. Restor Neurol Neurosci 1998; 13:185–191.
   Google Scholar
• Kim H and Kwon JS. Effects of placing micro-implants of melatonin in striatum on oxidative stress and neuronal damage mediated by N-methyl-D-asparate (NMDA) and non-NMDA receptors. Arch Pharm Res 1999; 22:33–43.
   Google Scholar
• Levine ME, Millliron AN, Duffy LK. Diurnal and seasonal rhythms of melatonin, cortisol and testosterone in interior Alaska. Arctic Med Res 1994; 53:25–34.
   Google Scholar
• Lezoualc’h R, Skeutella T, Widmann M, et al. Melatonin prevents oxidative stress-induced cell depth in hippocampal cells. Neuroreport 1996: 7:2071–2077.
   Google Scholar
• Love S. Oxidative stress in brain ischemia. Brain Path 1999; 9:119–131.
   Web of Science ®Google Scholar
• Mattson MP, Mark RJ, Furukawa K, et al. Disruption of brain cell ion hemostasis in Alzheimer’s Disease by oxy radicals, and signaling pathways that protect therefrom. Chem Res Toxicol 1997; 10:507–517.
   Web of Science ®Google Scholar
• Norlund JJ, and Lerner AB. The effects of oral melatonin on skin color and on the release of pituitary hormone. J Clin Endocrinol Metab 1997; 45:768–774.
   Google Scholar
• Nunomura A, Perry G, Pappolla, MA, et al. RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer’s disease. J Neurosci 1999; 19:1959–1964.
   PubMed Web of Science ®Google Scholar
• Olney JW, Price MT, Samson L, et al. The role of specific ions in glutamate toxicity. Neurosci Lett 1986; 65:65–71.
   PubMed Web of Science ®Google Scholar
• Poeggeler B, Reiter RJ, Tan DX, et al. Melatonin, hydroxyl-radical-mediated oxidative damage and aging: a hypothesis. J Pineal Research, 1993; 14:151–168.
   PubMed Web of Science ®Google Scholar
• Reiter RJ, Tan DX, Cabrera J, et al. The oxidant/antioxidant network: role of melatonin. Biol Sign Recept 1999; 8:56–63.
   PubMedGoogle Scholar
• Skene DJ, Vivien-Roels, B, Sparks DL, et al. Daily variation in the concentration of melatonin and 5-hydroxyltryphtol in human pineal gland: effect of age and Alzheimer’s disease. Brain Res 1990; 528:170–174.
   PubMed Web of Science ®Google Scholar
• Smith MA, Kutty RK, Richey PL, et al. Heme oxygenase-1 is associated with the neurofibrillary pathology of Alzheimer’s disease. Am J Pathol 1994; 145:42–47.
   PubMed Web of Science ®Google Scholar
• Smith MA, Harris PLR, Sayre LM, et al. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. Proc Natl Acad Sci USA 1997; 94:9866–9868.
   PubMed Web of Science ®Google Scholar
• Smith MA, Hirai K, Hsiao K, et al. Amyloid deposition in Alzheimer transgenre mice is associated with oxidative stress. J Neurochem 1998; 70:2212–2215.
   PubMed Web of Science ®Google Scholar
• Stadtman ER, and Berlett BS. Reactive oxygen-mediated protein oxidation in aging and disease. Chem Res Toxicol. 1997; 10:485–494.
   PubMed Web of Science ®Google Scholar
• Uz T, Giusti P Franceschini D, Kharlamou A, et al. Protective effect of melatonin against hippocampal RNA damage induced by intra-peritoneal administration of kainite to rats. Neurosci. 1996; 73: 631–6.
   PubMed Web of Science ®Google Scholar
• Wakatsuki A, Okatani Y, Izumiya C, et al. Melatonin protects against ischemia and reperfusion-induced oxidative lipid and DNA damage in fetal rat brain. J Pineal Res 1999; 26:147–152.
   PubMed Web of Science ®Google Scholar